Cloned helper and cytotoxic T lymphocytes as effector cells in adoptive immunotherapy of murine leukemia.
Bookman
M A
MA
Medicine Branch, National Cancer Institute, Bethesda, Maryland 20892.
Horak
E
E
de Graaf
P W
PW
D000818:Animals; D002999:Clone Cells / Q000276:immunology / Q000637:transplantation; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007116:Immunization, Passive; D007371:Interferon-gamma / Q000627:therapeutic use; D007942:Leukemia, Experimental / Q000276:immunology / Q000628:therapy*; D008212:Lymphocyte Depletion; D051379:Mice; D008810:Mice, Inbred C57BL; D011994:Recombinant Proteins / Q000627:therapeutic use; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000637:transplantation; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology* / Q000637:transplantation
D011994:Recombinant Proteins; D007371:Interferon-gamma; D003520:Cyclophosphamide